CROI 2017: What’s in store for ViiV Healthcare in Seattle?

Dr John Pottage, Chief Scientific and Medical Officer, explains why ViiV Healthcare is excited to attend CROI this year.

The annual Conference on Retroviruses and Opportunistic Infections (CROI) has facilitated some of the most important presentations in the field of HIV over the years. Scientific discoveries presented at the conference have led to great progress in HIV/AIDS research, and this is why we look forward to joining some of the world’s leading experts in HIV research this week in Seattle.

Every year CROI presents a unique forum for our medical and research experts to discuss the latest studies, exchange knowledge and strengthen collaborative networks with fellow HIV researchers. We believe this kind of collaboration with experts and external partners is crucial to advancing the science behind HIV treatment, prevention and care.

What to look forward to from ViiV Healthcare

Advances in anti-retroviral therapy over the past decade have resulted in people living with HIV (PLHIV) having longer, fuller lives. However, the requirements of PLHIV are diverse and evolving and many treatment-related needs still persist. Research into new medicines should aim to support a broad range of patients and offer continued improvements in efficacy and safety, as well as other important areas such as tolerability, resistance, dosing schedules, drug interaction and convenience.

These persisting needs are why we continue to focus relentlessly on finding new ways to innovate through R&D and partnerships, working with scientists around the world to deliver advances in options for treatment and prevention. At this year’s CROI, we look forward to presenting, for the first time, new clinical data from our latest phase III studies that explore the potential of two-drug regimens.

Leadership and innovation in HIV science

As HIV is a life-long, but increasingly manageable condition, our R&D ambition reflects the diverse and changing needs of PLHIV. Our current initiatives are to critically examine what is essential in HIV care and remain diligent to our research and the science, in the hope of finding answers that may help us and others improve the treatment options for all PLHIV.

For more information on ViiV Healthcare at CROI, please visit our media page to read our latest news. To our colleagues and partners attending the congress, we wish you a successful CROI 2017 and hope to see you in Seattle!